SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-105237
Filing Date
2021-08-13
Accepted
2021-08-13 17:12:13
Documents
5
Effectiveness Date
2021-08-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2124861d4_s8.htm S-8 49061
2 EXHIBIT 5.1 tm2124861d4_ex5-1.htm EX-5.1 12301
3 EXHIBIT 23.1 tm2124861d4_ex23-1.htm EX-23.1 1815
4 GRAPHIC tm2124861d4_5-1img001.jpg GRAPHIC 10415
5 GRAPHIC tm2124861d4_5-1img002.jpg GRAPHIC 692
  Complete submission text file 0001104659-21-105237.txt   79926
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258819 | Film No.: 211173309
SIC: 2836 Biological Products, (No Diagnostic Substances)